FN2 Earnings Intelligence
Zimmer Biomet Holdings, Inc. ratios (quarterly)
Zimmer Biomet Holdings, Inc. (ZBH) Ratios (quarterly) derived from persisted SEC financial facts.
Key Stats
USD in millions, except per-share values and percentages.
| Metric | 9/30/2024 | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 est. | 9/30/2026 est. |
|---|---|---|---|---|---|---|---|
| Market Cap | - | - | - | - | - | - | - |
| - Cash | $569 | $1,384.5 | $556.9 | $1,292.7 | $424.2 | - | - |
| + Debt | - | - | - | - | - | - | - |
| Enterprise Value | - | - | - | - | - | - | - |
| Revenue | $1,824.2 | $1,909.1 | $2,077.3 | $2,001.4 | $2,086.7 | $2,134.9 | $2,040.8 |
| % Growth | - | - | - | - | - | 2.8% | 2.0% |
| Gross Profit | $1,285.6 | $1,359.3 | $1,485.1 | $1,442.1 | $1,510.5 | - | - |
| % Margin | 70.5% | 71.2% | 71.5% | 72.1% | 72.4% | - | - |
| EBITDA | - | $546.7 | $571.8 | $634.9 | $643.2 | - | - |
| % Margin | - | 28.6% | 27.5% | 31.7% | 30.8% | - | - |
| Net Income | $249.1 | $182 | $152.8 | $230.9 | $238.1 | - | - |
| % Margin | 13.7% | 9.5% | 7.4% | 11.5% | 11.4% | - | - |
| Diluted EPS | $1.23 | $0.91 | $0.77 | $1.16 | $1.22 | $2.01 | $1.88 |
| % Growth | - | - | - | - | - | 161.1% | 61.9% |
| Operating Cash Flow | - | $382.8 | - | - | $359.4 | - | - |
| CapEx | - | $44.6 | - | - | $36.3 | - | - |
| Free Cash Flow | - | $338.2 | - | - | $323.1 | - | - |
Historical market capitalization is not persisted, so Market Cap and Enterprise Value remain unavailable rather than mixing today's market value into prior periods.
Income Statement
USD in millions, except per-share values and percentages.
| Metric | 9/30/2024 | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 est. | 9/30/2026 est. |
|---|---|---|---|---|---|---|---|
| Revenue | $1,824.2 | $1,909.1 | $2,077.3 | $2,001.4 | $2,086.7 | $2,134.9 | $2,040.8 |
| Gross Profit | $1,285.6 | $1,359.3 | $1,485.1 | $1,442.1 | $1,510.5 | - | - |
| EBITDA | - | $546.7 | $571.8 | $634.9 | $643.2 | - | - |
| Net Income | $249.1 | $182 | $152.8 | $230.9 | $238.1 | - | - |
| Diluted EPS | $1.23 | $0.91 | $0.77 | $1.16 | $1.22 | $2.01 | $1.88 |
Balance Sheet
USD in millions, except per-share values and percentages.
| Metric | 9/30/2024 | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | $569 | $1,384.5 | $556.9 | $1,292.7 | $424.2 |
| Short-term Debt | - | - | - | - | - |
| Long-term Debt | $4,737.7 | $6,576.3 | $6,752.5 | $7,512.6 | $6,295.1 |
| Total Debt | - | - | - | - | - |
Cash Flow
USD in millions, except per-share values and percentages.
| Metric | 9/30/2024 | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | $382.8 | - | - | $359.4 |
| Capital Expenditure | - | $44.6 | - | - | $36.3 |
| Free Cash Flow | - | $338.2 | - | - | $323.1 |
Ratios
USD in millions, except per-share values and percentages.
| Metric | 9/30/2024 | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 |
|---|---|---|---|---|---|
| Revenue Growth | - | - | - | - | - |
| Gross Margin | 70.5% | 71.2% | 71.5% | 72.1% | 72.4% |
| EBITDA Margin | - | 28.6% | 27.5% | 31.7% | 30.8% |
| Net Margin | 13.7% | 9.5% | 7.4% | 11.5% | 11.4% |
| FCF Margin | - | 17.7% | - | - | 15.5% |
| Diluted EPS Growth | - | - | - | - | - |